Compugen (CGEN) Tops Q3 EPS by 11c

Compugen (NASDAQ: CGEN) reported Q3 EPS of $0.01, $0.11 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $17.13 million versus the consensus estimate of $1.66 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
• Wall Street scrambles to lift Micron price targets ahead of earnings